Tislelizumab Antineoplastic Agents, Immunological
1 clinical trials · Condition
◉ Watch Tislelizumab Antineoplastic Agents, Immunological
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) (NCT04922047) | RenJi Hospital | 2021-06-01 |
Track Tislelizumab Antineoplastic Agents, Immunological automatically
Every clearance here is in the API, with alerts when new ones post.